| ACE | Angiotensin Converting Enzyme |
| ACTH | Adrenocorticotropic Hormone |
| ADE | Antibody-dependent Enhancement |
| AKI | Acute Kidney Injury |
| Anti-GBM | Anti-glomerular Basement Membrane Disease |
| ARB | Angiotensin Receptor Blockers |
| ARDS | Acute Respiratory Distress Syndrome |
| ASN | American Society of Nephrology |
| BMD | Bone Mass Density |
| CDC | United States Center for Disease Control |
| CIRCI | Critical Illness-related Corticosteroid Insufficiency |
| CK | Creatine kinase |
| COVID-19 | Coronavirus Disease 2019 |
| CRRT | Continuous Renal Replacement Therapy |
| CSF | CerebroSpinal Fluid |
| CT | Computed Tomography |
| CVD | Cardiovascular Disease |
| CVT | Cerebral Venus (sinus) Thrombosis |
| DIC | Disseminated Intravascular Coagulation |
| DPP4 | Dipeptidyl Peptidase 4 |
| DRA | Dopamine Receptor Agonist |
| ERA-EDTA | European Renal Association- European Dialysis and Transplant Association |
| ESS | Euthyroid Sick Syndrome |
| FDA | United States Food and Drug Administration |
| GAS | Gender Affirming Surgeries |
| GBS | Guillain-Barré syndrome |
| GH | Growth Hormone |
| GI | Gastrointestinal |
| HPA | Hypothalamus-pituitary-adrenal gland axis |
| IFN/ IFN-γ | Interferon-gamma |
| IHD | Intermittent Hemodialysis |
| MAC | Membrane Attack Complex |
| MASP 1 | MBP-associated serine protease 1 |
| MASP 2 | MBP-associated serine protease 2 |
| MBP | Mannan-binding protein |
| ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
| MERS-CoV | Middle East Respiratory Syndrome Coronavirus |
| MIS-C | Multi-system Inflammation Syndrome |
| MFS | Miller Fisher syndrome |
| MRI | Magnetic Resonance Imaging |
| NRP1 | Neuropilin-1 |
| N-protein | SARS-CoV-2 nucleocapsid protein |
| PACS | Post-acute COVID-19 Syndrome |
| PPE | Personal Protective Equipment |
| PRS | Proteomic Risk Score |
| RAAS | Renin Angiotensin Aldosterone System |
| RMD | Rheumatic and Musculoskeletal Disorders |
| SARS-CoV-1 | Severe Acute Respiratory Syndrome Coronavirus 1 |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| S-protein | SARS-CoV-2 spike protein |
| TGNC | Transgender and non-conforming individuals |
| TLR | Toll-like Receptor |
| TMPRSS2 | Transmembrane Serine Protease-2 |
| VEM | Viscoelastic Methods |
| VITT | Vaccine-induced Immune Thrombocytopenia and Thrombosis |
| VOC | Variants of Concern |
| VOI | Variants of Interest |
| WHO | World Health Organization |